All stocks · United States
Halozyme Therapeutics (HALO): stock price and analysis
Price as of 2026-11-06, updated daily · simple page
The short answer
Current trend (a fact, not a forecast)Mixed
The price is above its 200-session average and below its 50-session average. Over 3 months: +1.0%. The radar's AI does not give a call on this stock yet: nobody can reliably say whether it will rise next month.
How much does it usually move?±20% in a monthOver two years, 8 months in 10 between -11% and +18%
Key figures
| Last price | $103.63 (2026-11-06) |
|---|---|
| Day change | -15.72% |
| 1-year high | $131.18 |
| 1-year low | $61.63 |
| Max drawdown (1 year) | -24.1% |
| Volatility (last 20 sessions) | 72% a year |
| Best / worst month (2 years) | +38.3% / -23.7% |
| Country | United States |
| Sector | health care |
Other stocks from the same country
Simple page computed from public prices (Yahoo Finance). Key figures are past facts; the AI's call is a forecast, not a certainty. Educational project, not investment advice.